111 related articles for article (PubMed ID: 22217421)
1. Regulation of the mouse gene encoding TAFI by TNFα: role of NFκB binding site.
Garand M; Lin JH; Hill CE; Zagorac B; Koschinsky ML; Boffa MB
Cytokine; 2012 Mar; 57(3):389-97. PubMed ID: 22217421
[TBL] [Abstract][Full Text] [Related]
2. Nobiletin, a polymethoxyflavone in citrus fruits, reduces TAFI expression in HepG2 cells through transcriptional inhibition.
Takada K; Seike T; Sasaki T; Masuda Y; Ito A; Ishii H
Thromb Haemost; 2013 Jun; 109(6):1060-9. PubMed ID: 23572161
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of the human thrombin-activatable fibrinolysis inhibitor gene promoter.
Garand M; Bastajian N; Nesheim ME; Boffa MB; Koschinsky ML
Br J Haematol; 2007 Jul; 138(2):231-44. PubMed ID: 17593031
[TBL] [Abstract][Full Text] [Related]
4. Pro-inflammatory cytokines reduce human TAFI expression via tristetraprolin-mediated mRNA destabilisation and decreased binding of HuR.
Komnenov D; Scipione CA; Bazzi ZA; Garabon JJ; Koschinsky ML; Boffa MB
Thromb Haemost; 2015 Aug; 114(2):337-49. PubMed ID: 26062599
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the infection-responsive bovine lactoferrin promoter.
Zheng J; Ather JL; Sonstegard TS; Kerr DE
Gene; 2005 Jun; 353(1):107-17. PubMed ID: 15935571
[TBL] [Abstract][Full Text] [Related]
7. Role of NFkappaB in the regulation of macrophage colony stimulating factor by tumor necrosis factor-alpha in ST2 bone stromal cells.
Isaacs SD; Fan X; Fan D; Gewant H; Murphy TC; Farmer P; Taylor WR; Nanes MS; Rubin J
J Cell Physiol; 1999 May; 179(2):193-200. PubMed ID: 10199558
[TBL] [Abstract][Full Text] [Related]
8. The mRNA encoding TAFI is alternatively spliced in different cell types and produces intracellular forms of the protein lacking TAFIa activity.
Lin JH; Novakovic D; Rizzo CM; Zagorac B; Garand M; Filipieva A; Koschinsky ML; Boffa MB
Thromb Haemost; 2013 Jun; 109(6):1033-44. PubMed ID: 23595589
[TBL] [Abstract][Full Text] [Related]
9. TNF-alpha induced NFκB signaling and p65 (RelA) overexpression repress Cldn5 promoter in mouse brain endothelial cells.
Aslam M; Ahmad N; Srivastava R; Hemmer B
Cytokine; 2012 Feb; 57(2):269-75. PubMed ID: 22138107
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B.
Kleinert H; Euchenhofer C; Ihrig-Biedert I; Förstermann U
Mol Pharmacol; 1996 Jan; 49(1):15-21. PubMed ID: 8569701
[TBL] [Abstract][Full Text] [Related]
11. Genomic organization and promoter analysis of the mouse ADP-ribosylarginine hydrolase gene.
Aoki K; Kato J; Shoemaker MT; Moss J
Gene; 2005 May; 351():83-95. PubMed ID: 15893437
[TBL] [Abstract][Full Text] [Related]
12. The role of p105 protein in NFkappaB activation in ANA-1 murine macrophages following stimulation with titanium particles.
Soloviev A; Schwarz EM; Kuprash DV; Nedospasov SA; Puzas JE; Rosier RN; O'Keefe RJ
J Orthop Res; 2002 Jul; 20(4):714-22. PubMed ID: 12168659
[TBL] [Abstract][Full Text] [Related]
13. Induction of transcripts derived from promoter III of the acetyl-CoA carboxylase-alpha gene in mammary gland is associated with recruitment of SREBP-1 to a region of the proximal promoter defined by a DNase I hypersensitive site.
Barber MC; Vallance AJ; Kennedy HT; Travers MT
Biochem J; 2003 Oct; 375(Pt 2):489-501. PubMed ID: 12871210
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of erythropoietin gene expression signaling involves the transcription factors GATA-2 and NF-kappaB.
La Ferla K; Reimann C; Jelkmann W; Hellwig-Bürgel T
FASEB J; 2002 Nov; 16(13):1811-3. PubMed ID: 12223449
[TBL] [Abstract][Full Text] [Related]
15. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
Lou Z; Maher VM; McCormick JJ
Gene; 2005 May; 351():51-9. PubMed ID: 15857802
[TBL] [Abstract][Full Text] [Related]
16. Cloning and characterization of lipopolysaccharide-induced tumor necrosis factor alpha factor promoter.
Shiomi N; Myokai F; Naruishi K; Oyaizu K; Senoo K; Yamaguchi T; Amar S; Takashiba S
FEMS Immunol Med Microbiol; 2006 Aug; 47(3):360-8. PubMed ID: 16872372
[TBL] [Abstract][Full Text] [Related]
17. In vivo binding of NF-kappaB to the IkappaBbeta promoter is insufficient for transcriptional activation.
Griffin BD; Moynagh PN
Biochem J; 2006 Nov; 400(1):115-25. PubMed ID: 16792530
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the human intestinal CD98 promoter and its regulation by interferon-gamma.
Yan Y; Dalmasso G; Sitaraman S; Merlin D
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G535-45. PubMed ID: 17023546
[TBL] [Abstract][Full Text] [Related]
19. Sp1 and AP2 enhance promoter activity of the mouse GM3-synthase gene.
Xia T; Zeng G; Gao L; Yu RK
Gene; 2005 May; 351():109-18. PubMed ID: 15890474
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the human CIDEA promoter in fat cells.
Pettersson AT; Laurencikiene J; Nordström EA; Stenson BM; van Harmelen V; Murphy C; Dahlman I; Rydén M
Int J Obes (Lond); 2008 Sep; 32(9):1380-7. PubMed ID: 18607384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]